Arthur J. Klausner - 16 Dec 2025 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
Director
Signature
/s/ Quan Vu, Attorney-in-fact
Issuer symbol
MNPR
Transactions as of
16 Dec 2025
Net transactions value
$0
Form type
4
Filing time
17 Dec 2025, 15:41:41 UTC
Previous filing
08 Dec 2025
Next filing
19 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KLAUSNER ARTHUR J Director 1000 SKOKIE BLVD SUITE 350, WILMETTE /s/ Quan Vu, Attorney-in-fact 17 Dec 2025 0001207790

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNPR Common Stock Other $0 +7,710 +125% $0.000000 13,883 16 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pro rata distribution from Gem Pharmaceuticals, LLC, of which the reporting person is a non-managing member.